arrow
K

Kristina L. Bajema

veterans affairs portland health care system
H指数:20
被引数:2,259

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial

恩塞特雷韦治疗住院成人COVID-19:一项国际多中心III期随机安慰剂对照试验

2026-04-220
PRE
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients

IDSA 2025年关于在免疫抑制患者中预防季节性COVID-19、流感及RSV感染的疫苗使用指南

2026-03-020
PRE
Dissemination and Implementation of a Telehealth-Enabled Program for Providing Infectious Disease Expertise in Rural Settings

在乡村环境中传播和实施一项赋能远程医疗的传染病专家支持计划

2025-08-110
OA
Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras
2025-04-010
PRE
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study

呼吸道合胞病毒疫苗在美国退伍军人中的有效性:2023年9月至2024年3月——一项目标试验模拟研究

2025-01-010
PRE
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among US Veterans A Target Trial Emulation

Nirmatrelvir-ritonavir对美国退伍军人Post-COVID-19状况发展的有效性

2023-11-0117
OA
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among US Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes
2023-06-0133
OA
Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study
2023-05-234
OA
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection
2022-08-317
OAAI
Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States

肺炎球菌结合疫苗对美国抗生素非敏感性侵袭性肺炎球菌疾病的影响

2022-04-2829
OA